Pluralibacter gergoviae

Pluralibacter gergoviae (formerly Enterobacter gergoviae) is a Gram-negative, motile, facultatively-anaerobic, rod-shaped bacterium. "P. gergoviae" is of special interest to the cosmetics industry, as it displays resistance to parabens, a common antimicrobial agent added to cosmetic products.
Background.
"Enterobacter gergoviae" was first proposed as a novel species in 1980. The species name is derived from the Gergovie plateau, which is located near Clermont-Ferrand University Hospital; the type strain was isolated at this hospital during a nosocomial outbreak of "P. gergoviae." In 2013, the species was reclassified into the novel genus, "Pluralibacter", and is the type species for the genus.
"P. gergoviae" has been isolated from maize, grapes, coffee beans, spring water, fruit flies, and pink bollworms. It is an uncommon human pathogen, most commonly as an opportunistic nosocomial infection. One hospital in Spain reported the organism to represent 0.4% of clinical "Enterobacter" isolates. Risk factors include prolonged hospital stays, "immunosuppression, the presence of a foreign device, prior use of anti-microbial agents in the patient involved, and extremes of age." In the cosmetic industry, "P. gergoviae" has been implicated in recalls of eye cream, children's shampoo, skin cream, and hand cleaning paste.
"P. gergoviae" is resistant to penicillins (specifically benzylpenicillin, oxacillin), macrolides (with the exception of azithromycin), lincosamides (specifically lincomycin and clindamycin), streptogramins, rifampicin, fusidic acid, and fosfomycin. "P. gergoviae" is also resistant to cefoxitin, likely due to β-lactamase production.